This medical clinic specializes in a wide range of neurological conditions such as migraines, brain infections, spinal cord injuries, and neuromuscular disorders like amyotrophic lateral sclerosis (ALS), among others.
The clinic takes a personalized approach to patient care. They partner with the patient and their primary care physician to develop a care plan that maximizes the patient's quality of life and keeps them moving forward.
The clinic uses advanced, cutting-edge technology to diagnose and monitor neurological disorders accurately. They are experts at detecting changes in the nervous system and use a number of tests to assess balance, reflexes, coordination, and brain function.
While there is no cure for many neurological disorders, the clinic offers promising new therapies that can repair and restore functions to improve well-being and help patients live a more independent life. The treatment depends on the severity of the condition and can range from managing symptoms to surgery.
The clinic is involved in a multicenter, international, randomized, placebo-controlled, double-blind, parallel group and event-driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA.